Detalhe da pesquisa
1.
Geriatric assessments and frailty scores in multiple myeloma patients: a needed tool for individualized treatment?
Curr Opin Oncol
; 33(6): 648-657, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534141
2.
Multidisciplinary tumor boards and their analyses: the yin and yang of outcome measures.
BMC Cancer
; 21(1): 173, 2021 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33596881
3.
Pomalidomide combinations are a safe and effective option after daratumumab failure.
J Cancer Res Clin Oncol
; 149(9): 6569-6574, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36781500
4.
Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors.
Cancers (Basel)
; 13(17)2021 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503130
5.
Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials.
Leuk Lymphoma
; 59(11): 2692-2699, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29569975